https://www.autolus.com/ 2025-04-17T11:52:17+00:00 https://www.autolus.com/about-us/ 2024-11-08T21:29:49+00:00 https://www.autolus.com/about-us/our-purpose/ 2025-09-23T14:18:19+00:00 https://www.autolus.com/about-us/our-partners/ 2024-07-09T11:09:02+00:00 https://www.autolus.com/about-us/leadership/ 2025-09-23T14:11:41+00:00 https://www.autolus.com/about-us/leadership/dr-christian-itin/ 2025-07-01T13:54:40+00:00 https://www.autolus.com/about-us/leadership/miranda-neville/ 2025-09-17T15:49:18+00:00 https://www.autolus.com/about-us/leadership/rob-dolski/ 2024-07-23T14:35:49+00:00 https://www.autolus.com/about-us/leadership/dr-martin-pule/ 2024-07-23T14:36:12+00:00 https://www.autolus.com/about-us/leadership/cintia-piccina/ 2025-11-12T14:54:03+00:00 https://www.autolus.com/about-us/leadership/christopher-vann/ 2024-07-23T14:36:27+00:00 https://www.autolus.com/about-us/leadership/dr-chris-williams/ 2024-07-23T14:36:57+00:00 https://www.autolus.com/about-us/leadership/dr-matthias-will/ 2024-09-30T14:41:35+00:00 https://www.autolus.com/about-us/leadership/alexander-swan/ 2024-07-23T14:36:20+00:00 https://www.autolus.com/about-us/leadership/dr-veronica-hersberger/ 2025-12-02T16:05:23+00:00 https://www.autolus.com/about-us/leadership/mike-bonney/ 2024-04-03T11:44:14+00:00 https://www.autolus.com/about-us/leadership/john-berriman/ 2023-11-17T10:31:50+00:00 https://www.autolus.com/about-us/leadership/cynthia-m-butitta/ 2021-12-02T10:51:16+00:00 https://www.autolus.com/about-us/leadership/linda-bain/ 2024-04-05T13:54:33+00:00 https://www.autolus.com/about-us/leadership/william-d-young/ 2021-12-02T10:50:51+00:00 https://www.autolus.com/about-us/leadership/dr-robert-iannone/ 2023-07-18T19:34:57+00:00 https://www.autolus.com/about-us/leadership/dr-lis-leiderman/ 2024-01-10T12:04:39+00:00 https://www.autolus.com/about-us/leadership/robert-w-azelby/ 2024-01-10T12:04:40+00:00 https://www.autolus.com/about-us/leadership/vesna-cizej/ 2024-11-05T10:22:23+00:00 https://www.autolus.com/about-us/leadership/alex-driggs/ 2024-07-23T14:37:14+00:00 https://www.autolus.com/about-us/leadership/dr-ravi-rao/ 2024-04-03T10:56:27+00:00 https://www.autolus.com/about-us/leadership/david-brochu/ 2025-09-17T15:36:04+00:00 https://www.autolus.com/about-us/leadership/dilip-patel/ 2025-03-20T14:10:11+00:00 https://www.autolus.com/about-us/leadership/dr-andrea-braun-scherhag/ 2024-08-08T14:20:04+00:00 https://www.autolus.com/about-us/leadership/markus-gruell/ 2024-08-08T14:18:46+00:00 https://www.autolus.com/about-us/leadership/claudia-mercedes-mayer/ 2025-09-17T15:36:50+00:00 https://www.autolus.com/about-us/leadership/patrick-mcilvenny/ 2025-11-07T14:30:34+00:00 https://www.autolus.com/about-us/leadership/ryan-richardson/ 2026-04-29T17:28:45+00:00 https://www.autolus.com/about-us/our-history/ 2025-09-23T14:09:23+00:00 https://www.autolus.com/about-us/culture-and-values/ 2024-11-27T08:32:35+00:00 https://www.autolus.com/about-us/compliance-program/ 2024-12-20T15:39:19+00:00 https://www.autolus.com/our-car-t-focus/ 2025-10-07T17:46:32+00:00 https://www.autolus.com/innovation/ 2025-04-17T11:52:24+00:00 https://www.autolus.com/innovation/chimeric-antigen-receptor-t-cell-therapy/ 2023-08-18T15:10:35+00:00 https://www.autolus.com/innovation/pipeline-products/ 2025-09-23T14:47:47+00:00 https://www.autolus.com/innovation/pipeline-products/our-products/ 2024-11-08T21:29:59+00:00 https://www.autolus.com/innovation/pipeline-products/obe-cel/ 2024-11-08T21:29:56+00:00 https://www.autolus.com/innovation/advanced-cell-programming/ 2025-09-23T14:56:44+00:00 https://www.autolus.com/innovation/manufacturing/ 2025-12-03T17:11:27+00:00 https://www.autolus.com/innovation/abstracts-publications/ 2024-02-22T12:03:34+00:00 https://www.autolus.com/innovation/abstracts-publications/durable-responses-and-low-toxicity-after-fast-off-rate-cd19-car-t-therapy-in-adults-with-relapsed-refractory-b-all/ 2022-12-21T14:31:10+00:00 https://www.autolus.com/innovation/abstracts-publications/safety-and-efficacy-of-auto1-a-fast-off-rate-cd19-car-in-relapsedrefractory-b-cell-non-hodgkins-lymphoma-b-nhl-and-chronic-lymphocytic-leukaemia-cll/ 2022-12-21T14:26:37+00:00 https://www.autolus.com/innovation/abstracts-publications/clonal-expansion-of-t-memory-stem-cells-determines-early-anti-leukemic-responses-and-long-term-car-t-cell-persistence-in-patients/ 2022-12-21T14:31:50+00:00 https://www.autolus.com/innovation/abstracts-publications/antitumor-activity-without-on-target-off-tumor-toxicity-of-gd2-chimeric-antigen-receptor-t-cells-in-patients-with-neuroblastoma/ 2022-12-21T14:35:33+00:00 https://www.autolus.com/innovation/abstracts-publications/a-primer-set-for-the-rapid-isolation-of-scfv-fragments-against-cell-surface-antigens-from-immunised-rats/ 2022-12-21T14:35:59+00:00 https://www.autolus.com/innovation/abstracts-publications/auto6ng-overcomes-immune-suppressive-mechanisms-in-the-tme-and-demonstrate-preclinical-anti-tumor-activity-in-gd2-expressing-solid-tumors/ 2022-12-21T14:36:26+00:00 https://www.autolus.com/innovation/abstracts-publications/enhanced-car-t-cell-expansion-and-prolonged-persistence-in-pediatric-patients-with-all-treated-with-a-low-affinity-cd19-car/ 2022-12-21T14:38:35+00:00 https://www.autolus.com/innovation/abstracts-publications/rapacasp9-a-rapamycin-activated-caspase-9-based-suicide-gene/ 2022-12-21T14:39:06+00:00 https://www.autolus.com/innovation/abstracts-publications/targeting-t-cell-receptor-β-constant-for-immunotherapy-of-t-cell-malignancies/ 2022-12-21T14:40:06+00:00 https://www.autolus.com/innovation/abstracts-publications/industrialization-of-an-academic-miltenyi-prodigy-based-car-t-process/ 2022-12-21T14:28:03+00:00 https://www.autolus.com/innovation/abstracts-publications/car-t-cells-with-dual-targeting-of-cd19-and-cd22-in-pediatric-and-young-adult-patients-with-relapsed-or-refractory-b-cell-acute-lymphoblastic-leukemia-a-phase-1-trial/ 2022-12-21T14:30:20+00:00 https://www.autolus.com/innovation/abstracts-publications/targeting-trbc2-for-the-treatment-of-t-cell-lymphomas/ 2022-12-21T14:36:52+00:00 https://www.autolus.com/innovation/abstracts-publications/rqr8-a-highly-compact-epitope-based-markersuicide-gene-for-easier-and-safer-t-cell-therapy/ 2022-12-21T14:40:32+00:00 https://www.autolus.com/innovation/abstracts-publications/anti-psma-humanized-car-t-cell-with-improved-persistence-and-resistance-to-tumor-microenvironment-for-metastatic-castration-resistant-prostate-cancer-mcrpc/ 2022-12-21T14:37:27+00:00 https://www.autolus.com/innovation/abstracts-publications/tetcar-tunable-control-of-car-t-cell-activity-through-tetracycline-mediated-disruption-of-protein-protein-interaction/ 2022-12-21T14:29:29+00:00 https://www.autolus.com/innovation/abstracts-publications/a-compact-and-simple-method-of-achieving-differential-transgene-expression-by-exploiting-translational-readthrough/ 2022-12-21T14:25:55+00:00 https://www.autolus.com/innovation/abstracts-publications/dual-antigen-targeting-with-co-transduced-cd1922-car-t-cells-may-prevent-antigen-negative-relapse-after-car-t-cell-therapy-for-relapsedrefractory-all-auto122/ 2023-03-17T05:50:02+00:00 https://www.autolus.com/innovation/abstracts-publications/safety-efficiency-and-long-term-follow-up-of-auto1-a-fast-off-rate-cd19-car-in-relapsedrefractory-b-cell-acute-lymphoblastic-leukaemia-b-all-and-other-b-cell-malignancies/ 2023-01-05T12:13:31+00:00 https://www.autolus.com/innovation/abstracts-publications/first-in-human-study-of-auto4-a-trbc1-targeting-car-t-cell-therapy-in-relapsedrefractory-trbc1-positive-peripheral-t-cell-lymphoma/ 2023-01-05T12:15:28+00:00 https://www.autolus.com/innovation/abstracts-publications/dual-targeting-of-cd19-and-cd22-with-bicistronic-car-t-cells-in-patients-with-relapsedrefractory-large-b-cell-lymphoma/ 2023-03-17T05:42:34+00:00 https://www.autolus.com/innovation/abstracts-publications/dual-targeting-of-cd19-and-cd22-against-b-all-using-a-novel-high-sensitivity-acd22-car/ 2023-04-05T10:18:42+00:00 https://www.autolus.com/innovation/abstracts-publications/novel-fas-tnfr-chimeras-that-prevent-fas-ligand-mediated-kill-and-signal-synergistically-to-enhance-car-t-cell-efficacy/ 2023-06-27T12:41:14+00:00 https://www.autolus.com/innovation/abstracts-publications/enhancing-car-t-cell-therapy-using-fab-based-constitutively-heterodimeric-cytokine-receptors/ 2023-06-27T12:23:50+00:00 https://www.autolus.com/innovation/abstracts-publications/limited-efficacy-of-april-car-in-patients-with-multiple-myeloma-indicate-challenges-in-the-use-of-natural-ligands-for-car-t-cell-therapy/ 2023-07-05T20:01:12+00:00 https://www.autolus.com/innovation/abstracts-publications/transcriptional-signatures-associated-with-persisting-cd19-car-t-cells-in-children-with-leukemia/ 2023-09-27T14:02:06+00:00 https://www.autolus.com/innovation/abstracts-publications/detection-and-quantification-of-integrated-vector-copy-number-by-multiplex-droplet-digital-pcr-in-dual-transduced-car-t-cells/ 2023-09-27T14:27:56+00:00 https://www.autolus.com/innovation/abstracts-publications/cd19cd22-targeting-with-co-transduced-car-t-cells-to-prevent-antigen-negative-relapse-after-car-t-cell-therapy-of-b-all/ 2023-10-06T09:55:57+00:00 https://www.autolus.com/innovation/abstracts-publications/large-scale-manufacturing-of-base-edited-chimeric-antigen-receptor-t-cells/ 2023-10-06T11:50:23+00:00 https://www.autolus.com/innovation/abstracts-publications/designer-small-molecule-control-system-based-on-minocycline-induced-disruption-of-protein-protein-interaction/ 2024-01-23T14:55:04+00:00 https://www.autolus.com/innovation/abstracts-publications/structure-guided-engineering-of-immunotherapies-targeting-trbc1-and-trbc2-in-t-cell-malignancies/ 2024-03-11T10:30:01+00:00 https://www.autolus.com/innovation/abstracts-publications/dual-t-cell-constant-β-chain-trbc-1-and-trbc2-staining-for-the-identification-of-t-cell-neoplasms-by-flow-cytometry/ 2024-03-11T11:00:47+00:00 https://www.autolus.com/innovation/abstracts-publications/trbc1-car-t-cell-therapy-in-peripheral-t-cell-lymphoma-a-phase-12-trial/ 2024-11-11T14:51:30+00:00 https://www.autolus.com/innovation/abstracts-publications/obecabtagene-autoleucel-in-adults-with-b-cell-acute-lymphoblastic-leukemia/ 2024-11-28T12:59:41+00:00 https://www.autolus.com/clinical-trials/ 2026-02-25T13:17:05+00:00 https://www.autolus.com/healthcare-professionals/ 2025-04-17T11:52:32+00:00 https://www.autolus.com/healthcare-professionals/information-for-us-healthcare-professionals/ 2025-09-23T15:16:04+00:00 https://www.autolus.com/healthcare-professionals/expanded-access-compassionate-use/ 2025-04-17T11:52:38+00:00 https://www.autolus.com/information-for-patients/ 2025-04-17T11:52:42+00:00 https://www.autolus.com/information-for-patients/us-patient-information/ 2025-04-17T11:52:45+00:00 https://www.autolus.com/information-for-patients/patient-care-guides/ 2025-09-23T15:19:03+00:00 https://www.autolus.com/careers/ 2025-09-30T16:11:48+00:00 https://www.autolus.com/investor-relations-media/ 2026-05-27T18:24:44+00:00 https://www.autolus.com/investor-relations-media/news-media/ 2025-10-08T16:08:25+00:00 https://www.autolus.com/investor-relations-media/events/ 2022-01-11T14:51:30+00:00 https://www.autolus.com/investor-relations-media/sec-filings/ 2022-01-11T14:51:02+00:00 https://www.autolus.com/investor-relations-media/quarterly-earnings/ 2026-05-19T16:15:49+00:00 https://www.autolus.com/investor-relations-media/stock-quote-chart/ 2025-10-07T18:06:56+00:00 https://www.autolus.com/investor-relations-media/historical-price-lookup/ 2025-10-07T18:08:35+00:00 https://www.autolus.com/investor-relations-media/analyst-coverage/ 2026-05-27T18:35:59+00:00 https://www.autolus.com/investor-relations-media/corporate-governance/ 2026-04-07T20:47:14+00:00 https://www.autolus.com/investor-relations-media/corporate-presentations/ 2026-05-27T18:22:48+00:00 https://www.autolus.com/investor-relations-media/agm/ 2025-06-26T15:48:45+00:00 https://www.autolus.com/investor-relations-media/investor-faqs/ 2025-09-23T15:48:22+00:00 https://www.autolus.com/investor-relations-media/investor-contacts/ 2025-01-13T18:37:07+00:00 https://www.autolus.com/investor-relations-media/email-alerts/ 2025-02-25T10:09:56+00:00 https://www.autolus.com/contact-us/ 2025-10-07T12:51:53+00:00 https://www.autolus.com/terms-of-use/ 2022-06-16T13:44:58+00:00 https://www.autolus.com/privacy-cookies/ 2025-09-26T14:53:16+00:00 https://www.autolus.com/cctv-privacy/ 2025-09-26T14:53:54+00:00 https://www.autolus.com/accessibility/ 2024-05-08T09:20:12+00:00 https://www.autolus.com/settings/ 2025-09-26T14:52:01+00:00 https://www.autolus.com/page-not-found/ 2021-10-12T12:31:17+00:00 https://www.autolus.com/search/ 2024-05-08T13:18:34+00:00